15 Purpose: 68 Ga-PSMA PET/CT is the most accurate imaging technique to detect
metastatic prostate cancer (mPCa), mainly at biochemical relapse. However, its role in …

We aimed to evaluate the role of PET targeting the prostate-specific membrane antigen
(PSMA) for response assessment in metastatic prostate cancer (PCa) patients treated with …

This study was performed to assess the prognostic utility of conventional biochemical and
imaging response criteria and 68Ga-PSMA11 PET–adapted or–specific systems regarding …

Purpose To investigate the value of 68 Ga-HBED-CC PSMA (68 Ga-PSMA) PET/CT for
response assessment in metastatic castration-sensitive and castration-resistant prostate …

35 Background: Imaging-based response to systemic therapies in metastatic prostate cancer
is still challenging. The aim of this study was to retrospectively investigate the association …

Background Treatment response is traditionally monitored using prostate-specific antigen
(PSA) and conventional imaging in patients with metastatic prostate cancer (mPCa) …

2204 Introduction: There is nowadays a lack of validated tools to follow-up patients under
treatment with Radium-223 apart from subjective clinical evaluation. Serum PSA and …

TO THE EDITOR: I have read with great interest the paper recently published in your journal
entitled,“68Ga-PSMA PET/CT for Response Assessment and Outcome Prediction in …

Purpose Prostate-specific membrane antigen (PSMA) positron emission tomography
(PET)/computed tomography (CT) is used for (re) staging prostate cancer (PCa) and as a …

For patients with metastatic castration-resistant prostate cancer (mCRPC), no reliable
biomarkers for predicting therapeutic response or assisting in treatment selection and …